Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityActive in the last 2 years

Hidemasa Kawabata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3657-1991; OpenAlex author ID A5021508179. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-026-02382-9↗
  2. Highly multiplexed digital PCR assay for simultaneous quantification of variant allele frequencies and copy number alterations of KRAS and GNAS in pancreatic c… Co-author DOI 10.1002/1878-0261.70011↗
  3. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA. Co-author DOI 10.1097/mpa.0000000000002315↗
  4. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. Co-author DOI 10.1007/s00535-021-01846-4↗
  5. Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model. Co-author DOI 10.1016/j.pan.2021.03.002↗
  6. Resection for pancreatic cancer metastases contributes to survival: A case report with sequential tumor genotype profiling during the long-term postoperative c… Co-author DOI 10.1097/md.0000000000020564↗
  7. Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB. Co-author DOI 10.1055/a-1034-7700↗
  8. Utility of "liquid biopsy" using pancreatic juice for early detection of pancreatic cancer. Co-author DOI 10.1055/a-0721-1747↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yusuke Mizukami · 8 shared papers, 2018–2026 · strength 1.09
  2. Hiroki Sato · 7 shared papers, 2018–2025 · strength 0.87
  3. Toshikatsu Okumura · 7 shared papers, 2018–2026 · strength 0.85
  4. Mikihiro Fujiya · 6 shared papers, 2019–2026 · strength 0.78
  5. Kenji Takahashi · 4 shared papers, 2022–2026 · strength 0.74
  6. Tetsuhiro Okada · 6 shared papers, 2018–2026 · strength 0.68
  7. Yohei Kitano · 2 shared papers, 2024–2026 · strength 0.39
  8. Kazuya Koyama · 2 shared papers, 2024–2026 · strength 0.39
  9. Junpei Sasajima · 4 shared papers, 2018–2021 · strength 0.35
  10. Andrew Scott Liss · 2 shared papers, 2022–2025 · strength 0.35
  11. Junko Tanaka · 1 shared paper, 2025 · strength 0.24
  12. Takahide Yokoi · 1 shared paper, 2025 · strength 0.24
  13. Yuko Omori · 2 shared papers, 2018–2019 · strength 0.14
  14. Hiroaki Konishi · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.